Borosil Scientific logo

Borosil Scientific financials and balance sheet

NSE: BOROSCIBSE: 544184Industrial ProductsSmall Cap

Last close ₹106.15up ₹0.40 (0.38%)BSE ₹104.90

Share price at the NSE close on 23 Oct 2026. Previous close ₹105.75.

52-week range of traded prices to 23 Oct 2026
₹96.64Low, 30 Mar 2026₹180.80High, 29 Jun 2026
Market cap
₹944 Cr1,443rd largest listed
P/E
21.9
P/B
2.1
Dividend yield
Nonein the last 12 months
ROE
10.2%
ROCE
10.3%
Debt to equity
0.02
Volume, NSE
61,26260.3% delivered

3 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Borosil Scientific annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹467 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue467
  2. Materials and goods−167
  3. Employee costs−80
  4. Other expenses−158
  5. Operating profit62
  6. Depreciation−19
  7. Other income+9.5
  8. One-off items−8.5
  9. Finance costs−1.1
  10. Profit before tax43
  11. Tax−8.3
  12. Net profit35

What the company owns

  • Plant, investments and other assets₹234 Cr
  • Current investments₹122 Cr
  • Inventory₹103 Cr
  • Receivables₹76 Cr
  • Cash and bank₹14 Cr

What pays for it: net worth and liabilities

  • Net worth₹441 Cr
  • Other liabilities₹57 Cr
  • Owed to suppliers₹42 Cr
  • Borrowings₹8 Cr

Borosil Scientific business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them. A segment at a loss has no share of profit.Borosil Scientific segment results by quarter

Revenue by segment

₹467 CrTotal
  • Scientific-Laboratory Glass and Equipment and process system₹331 Cr70.8% of total
  • Glassware₹131 Cr28.0% of total
  • Others₹6 Cr1.2% of total

Profit by segment

  • Scientific-Laboratory Glass and Equipment and process system₹75.4 Cr97.3% of total
  • Others₹2.1 Cr2.7% of total

Segment results by year

Consolidated, ₹ crore, years to March.

  • Scientific-Laboratory Glass and Equipment and process system

    Revenue, ₹ crore
    Profit, ₹ crore
  • Glassware

    Revenue, ₹ crore
    Profit, ₹ crore
  • Others

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2024Mar 2025Mar 2026
Revenue of all businesses395438467
Company revenue, as in its results395438467
Revenue–310331
Revenue growth––6.8%
Profit–7075
Profit growth––7.4%
Margin–22.7%22.8%
Return on capital–46.9%50.1%
Assets–205213
Liabilities–5663
Capital employed–150150
Revenue–124131
Revenue–56
Revenue333––
Revenue62––
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.Borosil Scientific quarterly results

₹ croreMar 2024Filed 9 AugMar 2025Filed 12 JunMar 2026Filed 20 May
Revenue from operations395438467
349386405
Materials and goods bought145161167
Employee costs757780
Other expenses129147158
Operating profit before depreciation455362
Operating margin11.5%12.0%13.3%
Materials, % of revenue36.7%36.8%35.7%
Employee costs, % of revenue19.1%17.6%17.2%
Other expenses, % of revenue32.8%33.6%33.8%
Depreciation and amortisation161819
Operating profit after depreciation293443
Other income5810
Finance costs321
Profit before one-off items and tax324051
One-off items00−9
Profit before tax324043
8148
232735
Other comprehensive income000
Total comprehensive income232735
Net margin6.0%6.1%7.4%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2024Filed 9 AugMar 2025Filed 12 JunMar 2026Filed 20 May
376405441
376404441
Share capital999
Reserves367395432
Belonging to outside owners of subsidiaries000
17148
1008793
171715
Total assets493509549
203199214
291310335
Net debt3−106−128
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2024Filed 9 AugMar 2025Filed 12 JunMar 2026Filed 20 May
3012043
4613158
−572−2
Receivables−21−9−5
Inventories70−7
Payables19−68
Other working capital−10863
Tax paid−15−11−14
Capital spending131428
Free cash flow1710615
−2−115−37
−16−3−6
Dividends paid000
Shares bought back000
Shares issued000
Net change in cash1210
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2024Filed 9 AugMar 2025Filed 12 JunMar 2026Filed 20 May
Earnings per share₹2.65₹3.02₹3.89
Diluted earnings per share₹2.65₹3.02₹3.89
Book value per share₹42.33₹45.47₹49.61
Shareholder yield–0.0%0.0%
Market cap at the year end (₹ crore)–1,086917

Ratios

Consolidated, years to March.Borosil Scientific PE ratio and valuation

RatioMar 2024Filed 9 AugMar 2025Filed 12 JunMar 2026Filed 20 May
Revenue growth–11.1%6.6%
Operating profit growth–16.2%18.3%
Net profit growth–13.8%29.4%
Earnings per share growth–14.0%28.8%
6.3%6.9%8.2%
–0.6 pts1.3 pts
From the net margin–0.1 pts1.5 pts
From asset turnover–0.6 pts0.1 pts
From borrowing–−0.1 pts−0.2 pts
Return on capital employed7.3%8.1%9.6%
Cash conversion127.8%449.2%125.1%
Interest cover10.722.138.1
Debt to equity0.040.030.02
Receivable days575959
Inventory days244218226
Payable days1027993
Cash conversion cycle, days199198192
Working capital days1759689
Asset turnover0.800.880.88
Assets per rupee of net worth1.311.281.25
Sales per rupee of plant3.193.653.84
Capital spending to depreciation0.780.771.48
Plant being built, % of plant in use0.7%1.2%7.2%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
6.5%
Cash from operations against operating profit
69.6%
Measure3 years
Return on equity, average7.1%
Return on capital employed, average8.3%
Operating margin, average12.3%
Net margin, average6.5%
Asset turnover, average0.85
Cash conversion cycle, days, average197
Interest cover, average23.6
Debt to equity, average0.03

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore3 yearsLatest year
Cash from operations19343
Cash from investing−155−37
Cash from financing−26−6
Capital spending5528
Dividends paid00
Shares bought back00
Shares issued for cash00
Borrowings raised30
Borrowings repaid256

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––8
Altman Z-scorePublished threshold 1.81–9.007.86
Beneish M-scorePublished threshold −1.78–−3.18−2.44
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–4.425.39
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––2.28
Receivables growth less revenue growthOur threshold 0 percentage points–3.640.74
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−11.923.65
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–−21.88−0.54
Assets under construction, years of additionsOur threshold 2 years of additions–0.090.42
Effective tax ratePublished threshold 17.16 per cent25.5833.8419.29
Tax charged less tax paid, % of profitOur threshold 10 percentage points−23.555.93−14.13
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
9 Dec 2025CARE Ratings Limited (opens in a new tab)Fund-based/Non-fund-based-LT/STCARE A+ / CARE A1+Review, Re-affirmStable96.47
9 Dec 2025CARE Ratings Limited (opens in a new tab)Fund-based - LT-Term LoanCARE A+Review, Re-affirmStable0.53
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.